scPharmaceuticals Inc. (SCPH)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 4.9800 |
| Open | 5.0800 |
| Bid | 4.9100 x 400 |
| Ask | 4.9700 x 100 |
| Day's range | 4.6200 - 5.1038 |
| 52-week range | 3.2400 - 8.5500 |
| Volume | |
| Avg. volume | 231,968 |
| Market cap | 178.109M |
| Beta (5Y monthly) | 0.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.4800 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.50 |
GlobeNewswirescPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease
FDA assigns Prescription Drug User Fee Act (PDUFA) target action date of March 6, 2025 BURLINGTON, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s Supp
Simply Wall St.When Will scPharmaceuticals Inc. (NASDAQ:SCPH) Breakeven?
We feel now is a pretty good time to analyse scPharmaceuticals Inc.'s ( NASDAQ:SCPH ) business as it appears the...
- Simply Wall St.
Increases to scPharmaceuticals Inc.'s (NASDAQ:SCPH) CEO Compensation Might Cool off for now
Key Insights scPharmaceuticals' Annual General Meeting to take place on 11th of June Total pay for CEO John Tucker...
© 2024 Yahoo. All rights reserved.